|
Contents
|
|
|
|
Brain
Tumors |
|
|
|
|
Atkins
CD
Treatment of venous thrombosis in patients with intracranial malignancies
J
Clin Oncol. 2008 Apr 10;26(11):1905
Full text |
Reprint
Alok A. Khorana, Charles W. Francis, Anna Falanga, and Gary H. Lyman
In Reply
J
Clin Oncol. 2008 Apr 10;26(11):
1906-1907
Full text |
Reprint
|
|
|
Steven J. Jubelirer
Venous Thromboembolism and
Malignant Brain Tumors: A Review
Clinical and Applied Thrombosis/Hemostasis, Apr 1996; vol. 2: pp. 130 -
136
Abstract
|
|
|
Gliomas |
|
|
|
|
Perry
SL, Bohlin C, Reardon DA, Desjardins A, Friedman AH, Friedman HS,
Vredenburgh JJ
Tinzaparin
prophylaxis against venous thromboembolic complications in brain tumor
patients
J Neurooncol.
2009 May 5. [Epub ahead of print]
Abstract
|
|
|
Silvani A, Gaviani P,
Lamperti E, Botturi A, Ferrari D, Simonetti G, Fariselli L, Salmaggi A.
Metabolic,
electrolytes disorders and tromboembolic risk in malignant glioma patients.
Neurol Sci. 2011
Oct 13. [Epub ahead of print]
Abstract |
Related articles
|
|
Streiff MB, Segal J, Grossman SA, Kickler TS, Weir EG
ABO blood group is a potent risk factor for venous
thromboembolism in patients with malignant gliomas
Cancer. 2004 Apr 15;100(8):1717-23
|
|
|
Glioblastoma |
|
|
|
|
Prayson NF, Angelov L, Prayson RA
Microscopic thrombi in glioblastoma multiforme do not predict the
development of deep venous thrombosis
Ann Diagn Pathol. 2009 Oct;13(5):291-6
Abstract
|
|
A.
Shet, A. E. Schorer, M. A. Kuskowski
Venous thromboembolism is common but does not alter
survival in glioblastoma multiforme
39th
ASCO Annual Meeting. Chicago, IL. May 31-June 3, 2003. Abstract No. 432
|
|